Skip to main content
JIUZHITANG CO.,LTD logo

JIUZHITANG CO.,LTD — Investor Relations & Filings

Ticker · 000989 ISIN · CNE000001394 LEI · 3003004OFW6FCZ34KN72 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,885 across all filing types
Latest filing 2025-06-19 Major Shareholding Noti…
Country CN China
Listing Shenzhen Stock Exchange 000989

About JIUZHITANG CO.,LTD

https://www.hnjzt.com

JIUZHITANG CO.,LTD. is a pharmaceutical enterprise specializing in the research, development, manufacturing, and distribution of Traditional Chinese Medicine (TCM). Established in 1650, the company is recognized as a time-honored brand with a heritage spanning over three centuries. Its core product portfolio includes a diverse range of TCM formulations, most notably Liuwei Dihuang Wan, donkey-hide gelatin (Ejiao), and various health supplements focused on chronic disease management and general wellness. The company operates modern production facilities that integrate traditional processing techniques with contemporary scientific standards and biotechnology. JIUZHITANG focuses on the modernization of TCM through clinical research and innovation, maintaining a distribution network that serves retail pharmacies and medical institutions to provide natural healthcare solutions.

Recent filings

Filing Released Lang Actions
关于5%以上股东部分股份解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement from a company regarding the release of pledged shares by a shareholder holding more than 5% of the company's shares. It details the number of shares released from pledge, the shareholder's total pledged shares, and related information. The document is short (1367 characters) and focuses on shareholding and pledge status updates. It does not contain financial statements, audit information, or management discussion. It is not a report or presentation but an announcement about a major shareholding change related to pledged shares. Therefore, the most appropriate classification is 'Major Shareholding Notification' (MRQ).
2025-06-19 Chinese
关于5%以上股东部分股份解除质押及质押的公告
Major Shareholding Notification Classification · 95% confidence The document is an announcement regarding the pledge and release of shares by a shareholder holding more than 5% of the company's shares. It details the number of shares pledged and released, the pledgee, and related dates. This type of disclosure is typical for notifications about significant shareholder share pledges or releases, which affect the company's capital structure but do not constitute a full financial report or earnings release. The document is relatively short (3177 characters) and focuses on share pledge status updates by a major shareholder. Therefore, it fits best under the category of Major Shareholding Notification (MRQ).
2025-06-16 Chinese
关于股票交易异常波动的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from 九芝堂股份有限公司 regarding abnormal stock price fluctuations over several trading days. It includes explanations about the company's investigation into the cause, confirmation of no undisclosed material information, and risk warnings to investors. The document does not contain financial statements, detailed financial data, or management discussion of results. It is a regulatory announcement related to stock trading behavior and compliance with disclosure rules. The document length is short (1191 characters), and it serves as a formal disclosure to the market rather than a financial report or meeting material. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2025-06-04 Chinese
关于全资子公司研发新药启动II期临床试验的公告
Regulatory Filings Classification · 95% confidence The document is a short announcement (1433 characters) from 九芝堂股份有限公司 about the initiation of a Phase II clinical trial by its wholly-owned subsidiary. It includes details about the clinical trial project, its approval, and potential impact on the company. There are no financial statements, no detailed financial data, or comprehensive report content. The document is an announcement of a corporate event related to R&D progress, not a financial report or regulatory filing of financial results. It is not a report publication announcement since it does not mention any report being published or attached. It is also not a management or board change announcement. The content fits best under a general regulatory announcement category for corporate disclosures that do not fit other specific categories. Therefore, the appropriate classification is Regulatory Filings (RNS).
2025-05-26 Chinese
关于对深圳证券交易所2024年年报问询函回复的公告
Annual Report Classification · 95% confidence The document is a detailed response to an inquiry letter from the Shenzhen Stock Exchange regarding the company's 2024 annual report. It contains extensive financial data, including revenue, net profit, quarterly breakdowns, product sales, and explanations for financial performance changes over multiple years. The content focuses on the company's annual financial results, reasons for performance fluctuations, and management's analysis and measures. This aligns with the characteristics of an Annual Report (10-K) or a detailed financial report covering a full fiscal year. The document is lengthy (15,000 characters) and contains substantive financial data and analysis, not merely an announcement or certification. Therefore, it should be classified as an Annual Report (10-K). FY 2024
2025-05-23 Chinese
关于撤销其他风险警示暨停复牌的公告
Regulatory Filings Classification · 95% confidence The document is an official announcement from 九芝堂股份有限公司 regarding the removal of a special risk warning on its stock and the resumption of trading after a suspension. It details the stock code, changes in stock trading status, and references to prior audit reports and regulatory compliance. The document is relatively short (2360 characters) and primarily serves as a formal notice about stock trading status changes, not a full financial report or audit report itself. It does not contain detailed financial statements or substantive financial data but rather informs about regulatory approval and stock trading conditions. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement that does not neatly fit into other specific categories like Annual Report or Audit Report.
2025-04-30 Chinese

Browse filings by year

26 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.